Mark is a healthcare services entrepreneur, with expertise in managed care, pharmaceutical marketing, and disease management. He is chair of the Zetema Project, a group of US healthcare leaders from both political parties and all major stakeholder segments aiming to inform the healthcare conversation through expert debate. He has authored four books and scores of […]Read More
Livingston, N.J. (February 16, 2017) – Zitter Health Insights (ZHI), has been providing life science, specialty pharmacy and managed care organizations insights that optimize patient access to medications for almost three decades. ZHI’s Specialty Pharmacy Patient Satisfaction Survey was created to address an unmet need for an independent and objective benchmarking study that compares […]Read More
Specialty Pharmacy Times® and Zitter Health Insights Introduce The Inaugural Specialty Pharmacy Patient Choice Awards Winners to be Revealed at Asembia 2017, Finalists and Winners to be Recognized in Upcoming Issues of Specialty Pharmacy Times® CRANBURY, N.J. (January 24, 2017) – Specialty Pharmacy Times®, a full-service media resource dedicated to the business and practice of […]Read More
September 26, 2016 — Zitter Health Insights, a business intelligence firm serving life science companies, specialty pharmacies and managed healthcare organizations focused on optimizing patient access to pharmaceuticals, today announced that founder and CEO Mark Zitter will step down from his leadership role. Current President John Monahan will be appointed CEO of the business upon Zitter’s transition to Chairman in January 2017.Read More
July 28, 2016 — Zitter Health Insights, a business intelligence company focused on issues of access for life sciences, pharmacy, and managed care companies, today launched Patient Support Program PRO (PSP PRO), the industry’s first independent assessment of the patient support programs used by millions of pharmaceutical and biotech consumers with chronic or ongoing medication needs.
PSP PRO is a syndicated report that measures standardized key performance indicators across multiple product brands in a selected therapeutic area. Patients evaluate their overall satisfaction with their brand’s support program, and provide specific reviews of program elements such as the enrollment hassle factor, the effectiveness and emotional impact of financial and telephone support services, and whether welcome materials are reassuring or overwhelming.Read More